Large-Scale Population Carrier Screening for Spinal Muscular Atrophy in Israel—Effect of Ethnicity on the False-Negative Rate

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Genetic Testing and Molecular Biomarkers

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/gtmb.2009.0089PMID 20373854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic Carrier Screening for Spinal Muscular Atrophy and Spinal Muscular Atrophy with Respiratory Distress 1 in an Isolated Population in Israel

  2008influential reference
• Quantification of SMN1 and SMN2 genes by capillary electrophoresis for diagnosis of spinal muscular atrophy

  2008cited by this paper
• Population screening and cascade testing for carriers of SMA

  2007cited by this paper
• The molecular basis of spinal muscular atrophy (SMA) in South African black patients.

  2007cited by this paper
• Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy.

  2006cited by this paper
• Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: A highly efficient and reliable carrier‐screening test

  2005cited by this paper
• Detection of homozygous and heterozygous SMN deletions of spinal muscular atrophy in a single assay with multiplex ligation-dependent probe amplification.

  2005cited by this paper
• Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population

  2005cited by this paper
• MLPA and MAPH: New techniques for detection of gene deletions

  2004cited by this paper
• Quantitative Analysis of SMN1 Gene and Estimation of SMN1 Deletion Carrier Frequency in Korean Population based on Real-Time PCR

  2004cited by this paper
• Carrier incidence for spinal muscular atrophy in southern Chinese

  2004influential reference
• Determination of SMN1 and SMN2 copy number using TaqMan™ technology

  2003cited by this paper
• Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling

  2003cited by this paper
• Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.

  2002cited by this paper
• Genetic risk assessment in carrier testing for spinal muscular atrophy.

  2002cited by this paper
• Genetic testing and risk assessment for spinal muscular atrophy (SMA)

  2002cited by this paper
• An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)

  2000cited by this paper
• Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy.

  1999cited by this paper
• Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling.

  1999cited by this paper
• Identification of a novel missense mutation of the SMNT gene in two siblings with spinal muscular atrophy

  1998cited by this paper
• Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

  1997cited by this paper
• Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism?

  1997cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• Epidemiology of spinal muscular atrophies in a sample of the Italian population.

  1992cited by this paper
• Prevalence of type I spinal muscular atrophy in North Dakota.

  1991cited by this paper
• Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3.

  1990cited by this paper
• Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q

  1990cited by this paper
• Population data on acute infantile and chronic childhood spinal muscular atrophy in Warsaw

  1990cited by this paper
• Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators.

  1990cited by this paper
• Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q1 1.2–13.3

  1990cited by this paper
• Classification of spinal muscular atrophies.

  1980cited by this paper

• Next generation sequencing is a highly reliable method to analyze exon 7 deletion of survival motor neuron 1 (SMN1) gene

  2022cites this paper
• Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review

  2017cites this paper
• Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials

  2013cites this paper
• Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

  2011cites this paper
• Detection of Spinal Muscular Atrophy Carriers in a Sample of the Brazilian Population

  2011cites this paper
• Large-scale population screening for spinal muscular atrophy: Clinical implications

  2011cites this paper